Home | cafepharma

Sponsored by:

Amarin: FDA Panel Date, Misplaced Hype For Fixed-Dose Combo
TheStreet.com Wed, 06/19/13 - 12:05 pm
tags: advisory panels, Amarin, FDA, Vascepa
Japan's Astellas looks to sell dermatology assets - sources
Reuters Wed, 06/19/13 - 11:16 am
tags: Astellas, dermatology, Japan, M&A
How Much? Teva Agrees To Disclose Executive Pay
Pharmalot Wed, 06/19/13 - 11:15 am
tags: executive pay, Teva
2 Biotech Approval Outcomes That Might Affect You
Motley Fool Wed, 06/19/13 - 11:08 am
tags: Afrezza, Contrave, drug approvals, MannKind, Orexigen
Eli Lilly: Cymbalta Antidepressant Sales Forecast
Seeking Alpha Wed, 06/19/13 - 11:05 am
tags: antidepressants, Cymbalta, Eli Lilly, Forest Labs
Zoetis Exchange Offer Update
Seeking Alpha Wed, 06/19/13 - 10:51 am
tags: animal health, Pfizer, Zoetis
The FDA Might Pull This Drug From the Market (and Why It Doesn't Matter)
Motley Fool Wed, 06/19/13 - 10:49 am
tags: Eli Lilly, FDA, Zyprexa Relprevv
Sarepta And Eteplirsen: Will 12 Patients Be Enough For The FDA?
Seeking Alpha Wed, 06/19/13 - 10:33 am
tags: Duchenne Muscular Dystrophy, eteplirsen, FDA, GSK, Sarepta
Protalix signs supply deal with Brazilian government for Gaucher disease treatment
Yahoo/AP Wed, 06/19/13 - 10:31 am
tags: Brazil, Gaucher disease, Protalix, UPLYSO
AstraZeneca, Bristol diabetes drug disappoints in key test
Reuters Wed, 06/19/13 - 10:28 am
tags: AstraZeneca, Bristol-Myers Squibb, diabetes, Onglyza
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
Minyanville Tue, 06/18/13 - 11:53 am
tags: Celldex, ImmunoCellular Therapeutics, immunotherapy, Northwest Biotherapeutics, OncoSec
Royalty Pharma lets takeover bid for drugmaker Elan expire, decides against court challenge
Yahoo/AP Tue, 06/18/13 - 11:42 am
tags: Elan, M&A, Royalty Pharma
Supreme Court Permits Antitrust Scrutiny Of Pharma Settlements Comment Now Follow Comments
Forbes Tue, 06/18/13 - 11:41 am
tags: antitrust, pay-for-delay, Supreme Court
Promoting biotech drugs pays off at $164K a year, almost 50% more than pharma
Fierce Pharma Tue, 06/18/13 - 11:11 am
tags: compensation, drug reps
FDA probes deaths of two patients on Lilly schizophrenia drug
Reuters Tue, 06/18/13 - 11:06 am
tags: Eli Lilly, FDA, schizophrenia, Zyprexa Relprevv
Osiris - Can Stem Cells Lead To Profits?
Seeking Alpha Tue, 06/18/13 - 10:02 am
tags: Osiris Therapeutics, stem cells
[video] Drugs IPOs Depend on Deals
TheStreet.com Tue, 06/18/13 - 10:00 am
tags: Bluebird Bio, Celgene, IPOs, Patient Care Technologies, Regado Biosciences, Roche
Vanda says Phase III study data shows cortisol rhythm restoration
Yahoo/Fly on the Wall Tue, 06/18/13 - 9:52 am
tags: cortisol, non-24 hour disorder, tasimelteon, Vanda
Where Is Biotechnology's Next 'Anti-PD-1'?
Seeking Alpha Tue, 06/18/13 - 9:50 am
tags: anti-PD-1 immunotherapy, Baxter International, Bristol-Myers Squibb, Dendreon, lambrolizumab, Merck, MPDL3208A, Provenge, Yervoy
Big Pharma's Intellectual Property Blues
Motley Fool Tue, 06/18/13 - 9:45 am
tags: Big Pharma, intellectual property, Myriad Genetics, Novartis, Pfizer
Isis Pharmaceuticals Making Antisense
Seeking Alpha Tue, 06/18/13 - 9:02 am
tags: antisense, Isis Pharmaceuticals
Roche's Tarceva Progresses in Japan
Yahoo/Zacks Tue, 06/18/13 - 8:59 am
tags: Japan, non-small cell lung cancer, Roche, Tarceva
BioScrip buying CarePoint for $223 million to expand at-home drug infusion business
Yahoo/AP Tue, 06/18/13 - 8:58 am
tags: at-home drug infusion, BioScrip, CarePoint, M&A
Successor To Humira? AbbVie And Galapagos Work On It
Seeking Alpha Tue, 06/18/13 - 8:54 am
tags: AbbVie, Chron's Disease, Eli Lilly, Galapagos, GLPG0634, Humira, Incyte, Pfizer, rheumatoid arthritis
With $135M rights deal, Questcor locks up rival to its pricey Acthar drug
Fierce Pharma Mon, 06/17/13 - 3:01 pm
tags: H.P. Acthar Gel, Novartis, Questcor
BMS makes another emerging market move with new Simcere deal
Fierce Pharma Mon, 06/17/13 - 2:57 pm
tags: Bristol-Myers Squibb, China, Simcere
Teva buys MicroDose for $165 million
First Word Mon, 06/17/13 - 12:54 pm
tags: M&A, MicroDose Therapeutx, Teva
The Supreme Court Tells FTC's And Drug Industry To Go To War
Forbes Mon, 06/17/13 - 12:51 pm
tags: Actavis, FTC, generics, pay-for-delay, Supreme Court
Merck, Pfizer Sue Mylan to Block Proposed Copy of AzaSite
Bloomberg Mon, 06/17/13 - 12:50 pm
tags: Azasite, generics, Merck, Mylan, Pfizer
Medivation retreats after J&J beefs up prostate cancer slate
The Fly on the Wall Mon, 06/17/13 - 12:37 pm
tags: Aragon, JNJ, M&A, Medivation, prostate cancer, Zytiga
Open Letter to Vivus Employees Released by First Manhattan Co.
Yahoo Mon, 06/17/13 - 12:04 pm
tags: cafepharma, Qsymia, shareholders, Vivus
Orphan drugmaker ViroPharma attracts takeover interest: sources
Reuters Mon, 06/17/13 - 11:52 am
tags: Biomarin, M&A, ViroPharma
Pfizer: Renal Cancer Treatment Sutent Sales Forecast
Seeking Alpha Mon, 06/17/13 - 11:00 am
tags: Pfizer, renal cancer, Sutent
Drugmakers Opened to ‘Pay for Delay’ Suits by High Court
Bloomberg Mon, 06/17/13 - 10:51 am
tags: generics, pay-for-delay, Supreme Court
Rexahn awarded U.S. patent for novel anti-cancer compounds
Yahoo/Fly on the Wall Mon, 06/17/13 - 9:49 am
tags: anti-tumor, patents, quinazoline, Rexahn
Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now
TheStreet.com Mon, 06/17/13 - 9:47 am
tags: Elan, M&A, Royalty Pharma
Citing Side Effects, Japan Pulls Recommendations For HPV Vaccines
Pharmalot Mon, 06/17/13 - 9:46 am
tags: Cervarix, Gardasil, GSK, HPV, Japan, Merck, vaccines
AstraZeneca signs obesity and diabetes pact with NGM
Pharma Times, UK Mon, 06/17/13 - 9:41 am
tags: AstraZeneca, diabetes, NGM Biopharmaceuticals, obesity
Amicus Delays U.S. Approval Filing for Fabry Disease Drug
TheStreet.com Mon, 06/17/13 - 9:31 am
tags: Amicus, Amigal, Fabry's disease, GSK
Lilly to take over development of potential diabetes treatment from Transition Therapeutics
Yahoo/AP Mon, 06/17/13 - 9:30 am
tags: diabetes, Eli Lilly, Transition Therapeutics, TT-401
Index Ventures Invests $11 Million on Clot-Busting Drug
Bloomberg Mon, 06/17/13 - 9:28 am
tags: clot-busting drugs, ichorcumab, Index Ventures, X01 Ltd.
Gilead's Potential Megablockbuster Raises the Bar
Motley Fool Mon, 06/17/13 - 9:24 am
tags: Gilead, hepatitis C, sofosbuvir
AbbVie announces preliminary results in Phase 1 study of ABT-199
Yahoo/Fly on the Wall Mon, 06/17/13 - 9:23 am
tags: AbbVie, ABT-199, chronic lymphocytic leukemia
Novo Nordisk shares hit by concerns over rival diabetes drugs
Reuters Mon, 06/17/13 - 9:17 am
tags: diabetes, dulaglutide, Eli Lilly, Lantus, Lyxumia, Novo Nordisk, Sanofi, Victoza
J&J to Buy Aragon Pharmaceuticals for Cancer Candidate
Bloomberg Mon, 06/17/13 - 9:15 am
tags: Aragon, ARN-509, JNJ, M&A, prostate cancer
Biotechs Lose Ground As Achillion Takes a Dive
The Motley Fool Sun, 06/16/13 - 11:33 am
tags: Achillion, biotech, stock
Incyte Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients with Myelofibrosis
Yahoo/BusinessWire Sun, 06/16/13 - 11:33 am
tags: clinical trials, Incyte, Jakafi, myelofibrosis
Abbott Declares Dividend and $3 Billion Buyback Plan
The Motley Fool Sun, 06/16/13 - 11:28 am
tags: Abbott, dividend, stock, stock buyback
Uncle Sam Taps Big Pharma to Combat Antibiotic Resistance
The Motley Fool Sun, 06/16/13 - 11:27 am
tags: antibiotic resistance, government
Another Alzheimer's Disease Failure
The Motley Fool Sun, 06/16/13 - 11:25 am
tags: Alzheimer's disease, Eli Lilly

Company	Average	Last 24h	Increase
Vascular Solutions	12	22	83 %
Baxter International	17	31	82 %
Merck	17	30	76 %
China Medical Technologies	12	21	75 %
Bracco	4	7	75 %
vascular imaging	8	14	75 %
Elan	21	36	71 %
Calgary Scientific	7	12	71 %
Biogen Idec	3	5	67 %
C.R. Bard	3	5	67 %

Company	Average	Last 24 hrs	Increase
ConvaTec	2	4	100 %
BioWa	1	2	100 %
Dynavax	4	8	100 %
Omeros	1	2	100 %
Athenahealth	26	51	96 %
Covidien	24	45	88 %
Wellpoint	34	63	85 %
Oxigene	11	20	82 %
Zoetis	28	50	79 %
OncoSec	17	30	76 %

current news

CP Wire

Companies With 50%+ Increase in Blog Mentions

Companies With 50%+ Increase in Twitter Posts

news tags